GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study.

Medicina (Kaunas) · 2026 · PMC12843924 · PMID 41597428

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

One-way ANOVA revealed highly significant treatment effects on circulating cTnT (F(3,24) = 32.166, p < 0.001), CK (F(3,24) = 23.908, p < 0.001), CK-MB levels (F(3,24) = 26.760, p < 0.001) and LDH (F(3,24) = 146.200, p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.